Halozyme Therapeutics Inc (HALO)

Exchange
NASDAQ
Symbol
HALO
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company is headquartered in San Diego, California.
Country
USA

Stock price

At close: July 11, 2025

  • Open
    57.37
  • High
    57.86
  • Low
    56.79
  • Close
    57.15
  • Volume
    1,242,860

Financial ratios

Dec 31, 2024